BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1343 related articles for article (PubMed ID: 7993409)

  • 1. Mortality in sickle cell disease. Life expectancy and risk factors for early death.
    Platt OS; Brambilla DJ; Rosse WF; Milner PF; Castro O; Steinberg MH; Klug PP
    N Engl J Med; 1994 Jun; 330(23):1639-44. PubMed ID: 7993409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pain in sickle cell disease. Rates and risk factors.
    Platt OS; Thorington BD; Brambilla DJ; Milner PF; Rosse WF; Vichinsky E; Kinney TR
    N Engl J Med; 1991 Jul; 325(1):11-6. PubMed ID: 1710777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of adverse outcomes in children with sickle cell disease.
    Miller ST; Sleeper LA; Pegelow CH; Enos LE; Wang WC; Weiner SJ; Wethers DL; Smith J; Kinney TR
    N Engl J Med; 2000 Jan; 342(2):83-9. PubMed ID: 10631276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group.
    Vichinsky EP; Neumayr LD; Earles AN; Williams R; Lennette ET; Dean D; Nickerson B; Orringer E; McKie V; Bellevue R; Daeschner C; Manci EA
    N Engl J Med; 2000 Jun; 342(25):1855-65. PubMed ID: 10861320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality in children and adolescents with sickle cell disease. Cooperative Study of Sickle Cell Disease.
    Leikin SL; Gallagher D; Kinney TR; Sloane D; Klug P; Rida W
    Pediatrics; 1989 Sep; 84(3):500-8. PubMed ID: 2671914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized study of outpatient treatment with ceftriaxone for selected febrile children with sickle cell disease.
    Wilimas JA; Flynn PM; Harris S; Day SW; Smith R; Chesney PJ; Rodman JH; Eguiguren JM; Fairclough DL; Wang WC
    N Engl J Med; 1993 Aug; 329(7):472-6. PubMed ID: 8332152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early onset dactylitis associated with the occurrence of severe events in children with sickle cell anaemia. The Paediatric Cohort of Guadeloupe (1984-99).
    Foucan L; Ekouevi D; Etienne-Julan M; Salmi LR; Diara JP;
    Paediatr Perinat Epidemiol; 2006 Jan; 20(1):59-66. PubMed ID: 16420342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of influence of fetal hemoglobin levels or erythrocyte indices on the severity of sickle cell anemia.
    Powars DR; Schroeder WA; Weiss JN; Chan LS; Azen SP
    J Clin Invest; 1980 Mar; 65(3):732-40. PubMed ID: 6153392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sickle cell chronic lung disease: prior morbidity and the risk of pulmonary failure.
    Powars D; Weidman JA; Odom-Maryon T; Niland JC; Johnson C
    Medicine (Baltimore); 1988 Jan; 67(1):66-76. PubMed ID: 3336282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newborn screening for sickle cell disease: effect on mortality.
    Vichinsky E; Hurst D; Earles A; Kleman K; Lubin B
    Pediatrics; 1988 Jun; 81(6):749-55. PubMed ID: 3368274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing clinical severity in children with sickle cell disease. Preliminary results from a cooperative study.
    Bray GL; Muenz L; Makris N; Lessin LS
    Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):50-4. PubMed ID: 8311173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The global impact of noncommunicable diseases: estimates and projections.
    Manton KG
    World Health Stat Q; 1988; 41(3-4):255-66. PubMed ID: 3232413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute splenic sequestration in female children with sickle cell disease in the North of Jordan.
    Al-Rimawi HS; Abdul-Qader M; Jallad MF; Amarin ZO
    J Trop Pediatr; 2006 Dec; 52(6):416-20. PubMed ID: 16951418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Blood Disorders Survey in the Sultanate of Oman.
    Al-Riyami A; Ebrahim GJ
    J Trop Pediatr; 2003 Jul; 49 Suppl 1():i1-20. PubMed ID: 12934793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sickle cell disease as a cause of osteonecrosis of the femoral head.
    Milner PF; Kraus AP; Sebes JI; Sleeper LA; Dukes KA; Embury SH; Bellevue R; Koshy M; Moohr JW; Smith J
    N Engl J Med; 1991 Nov; 325(21):1476-81. PubMed ID: 1944426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow transplantation for sickle cell disease.
    Walters MC; Patience M; Leisenring W; Eckman JR; Scott JP; Mentzer WC; Davies SC; Ohene-Frempong K; Bernaudin F; Matthews DC; Storb R; Sullivan KM
    N Engl J Med; 1996 Aug; 335(6):369-76. PubMed ID: 8663884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.
    SociƩ G; Stone JV; Wingard JR; Weisdorf D; Henslee-Downey PJ; Bredeson C; Cahn JY; Passweg JR; Rowlings PA; Schouten HC; Kolb HJ; Klein JP
    N Engl J Med; 1999 Jul; 341(1):14-21. PubMed ID: 10387937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease.
    Griffin TC; McIntire D; Buchanan GR
    N Engl J Med; 1994 Mar; 330(11):733-7. PubMed ID: 8107739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glomerular involvement in adults with sickle cell hemoglobinopathies: Prevalence and clinical correlates of progressive renal failure.
    Guasch A; Navarrete J; Nass K; Zayas CF
    J Am Soc Nephrol; 2006 Aug; 17(8):2228-35. PubMed ID: 16837635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circumstances of death in adult sickle cell disease patients.
    Darbari DS; Kple-Faget P; Kwagyan J; Rana S; Gordeuk VR; Castro O
    Am J Hematol; 2006 Nov; 81(11):858-63. PubMed ID: 16924640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 68.